Minerva Neurosciences Stock (NASDAQ: NERV) stock price, news, charts, stock research, profile.
Open | $2.530 |
Close | $2.520 |
Volume / Avg. | 2.186K / 104.638K |
Day Range | 2.505 - 2.540 |
52 Wk Range | 2.286 - 13.490 |
Market Cap | $17.833M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 0.65% |
Days to Cover | 1.66 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Minerva Neurosciences (NASDAQ: NERV) through any online brokerage.
Other companies in Minerva Neurosciences’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Galecto (NASDAQ:GLTO), Serina Therapeutics (AMEX:SER), Immuron (NASDAQ:IMRN) and Imunon (NASDAQ:IMNN).
The latest price target for Minerva Neurosciences (NASDAQ: NERV) was reported by HC Wainwright & Co. on Thursday, May 2, 2024. The analyst firm set a price target for 7.00 expecting NERV to rise to within 12 months (a possible 174.51% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Minerva Neurosciences (NASDAQ: NERV) is $2.55 last updated May 16, 2024 at 7:01 PM EDT.
There are no upcoming dividends for Minerva Neurosciences.
Minerva Neurosciences’s Q2 earnings are confirmed for Tuesday, July 30, 2024.
There is no upcoming split for Minerva Neurosciences.
Minerva Neurosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.